Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Daily Brief: Theresa May and the diabetes sensor, Biosimilars hit Roche in Europe, Gilead CEO to step down

Daily Brief: Theresa May and the diabetes sensor, Biosimilars hit Roche in Europe, Gilead CEO to step down More biosimilar erosion in Europe is close at hand, however: 2018 will see the decline in Herceptin (-5% this quarter) and Avastin (-2%) accelerate.

Daily Brief: Amgen offers Repatha deals in Europe, will Persephone slash Herceptin use?

Daily Brief: Amgen offers Repatha deals in Europe, will Persephone slash Herceptin use? Herceptin, which could reduce their risk of heart damage while making significant cost-savings for the NHS. ... Herceptin remains one of the most important advances in breast cancer treatment in decades.

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more Biosimilars: Herzuma launched in Europe, FDA rejects Sandoz rituximab. Mundipharm has launched Herzuma, its biosimilar version of Roche’s Herceptin trastuzumab in Europe. ... This follows hot on the heels of MSD (working with Samsung Bioepsis) that

CHMP backs first-line use for AZ’s Tagrisso in lung cancer

CHMP backs first-line use for AZ’s Tagrisso in lung cancer alongside its older HER2 drug Herceptin (trastuzumab). ... The company is positioning Perjeta as a successor to HER2 stalwart Herceptin - which is starting to feel the effects of biosimilar competition - and approval for adjuvant use is another step

Ocrevus helps Roche stave off biosimilar threat

Ocrevus helps Roche stave off biosimilar threat stable sales for cancer antibodies Herceptin (trastuzumab) and Avastin (bevacizumab) - has given Roche the confidence to raise its annual sales and earnings forecasts for 2018. ... The accelerating decline reveals Roche’s vulnerability as biosimilars

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics